ARCHIVES

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Evaluation Of Potential Immunoassay Components Sought; Promising Results Could Lead to Contract

September 19, 1975

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

June 7, 2002

Professional Societies: ASCO opposes FDA On Stem Cell Transplant Regs

May 16, 1997

NCI, NINCDS Need Patients For Brain, Breast Studies

September 10, 1982

More Oncopathology Research Asked

June 30, 1978

ASCO to Present 2013 Special Awards at Annual Meeting

May 31, 2013